A marketing authorization is a legal decision by a national or regional regulatory authority permitting a medicinal product to be placed on a specific market for approved indications and under defined conditions. It appears in the approval letter or marketing authorization application dossier and defines the product information, labeling, packaging, and supply conditions under which the product can be promoted and distributed.
In translation and localization, marketing authorization appears in regulatory submission dossiers, approval letters, product information, and lifecycle documentation. Translators may support MA applications or post-approval variations by translating summary-of-product-characteristics, labeling, and patient information across EU languages and local markets.
A common mistake is translating “marketing authorization” as “marketing approval” or “product registration” in contexts where that suggests less than the full regulatory decision. Equating MA with patent or trademark rights is also misleading and can confuse labeling, advertising, and supply obligations.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →